Swiss Regulation on integrity and transparency in the field of medicinal products entered into effect on 1 January
Posted on 06.02.2020
On 1 January, the Swiss Regulation on integrity and transparency in the field of medicinal products entered into effect. The legislation regulates the details on integrity and the duty of transparency according to Articles 55 and 56 of the Swiss Therapeutic Products Act.
It provides, inter alia, the definition of gifts of modest value, an overview of the rules around educational support for Healthcare professionals (HCPs), and the Transparency obligations under the Swiss regime. The official text is available in German, French and Italian.